Enhanced Guide Extension System for the Efficient Delivery of Leads
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 17/304,786, filed Jun 25, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,903,613 | Enhanced Guide Extension System for the Efficient Delivery of Leads In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | ||
| US 11,998,236 | Enhanced Guide Extension System for the Efficient Delivery of Leads In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | ||
| US 12,268,417 | Enhanced Guide Extension System for the Efficient Delivery of Leads In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | ||
| US 11,712,266 | Enhanced Guide Extension System for the Efficient Delivery of Leads In force · High confidence | Vantis Vascular, Inc. | In force | High confidence | ||
| Application 19/068,407 | Intravascular Delivery Systems Pending Not granted | Crossliner, Inc. | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Vantis Vascular, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.